Farther Finance Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$358K Buy
16,406
+3,082
+23% +$90K ﹤0.01% 1852
2026
Q2
$482K Buy
13,324
+1,647
+14% +$56.3K ﹤0.01% 1587
2026
Q1
$388K Buy
11,677
+1,450
+14% +$61.4K ﹤0.01% 1573
2025
Q4
$474K Sell
10,227
-1,287
-11% -$53.8K 0.01% 1342
2025
Q3
$403K Sell
11,514
-645
-5% -$22.4K 0.01% 1197
2025
Q2
$360K Buy
12,159
+1,068
+10% +$30.5K 0.01% 1085
2025
Q1
$326K Buy
11,091
+477
+4% +$14.6K 0.01% 1002
2024
Q4
$304K Sell
10,614
-1,064
-9% -$35.2K 0.01% 801
2024
Q3
$451K Buy
11,678
+11,466
+5,408% +$409K 0.02% 635
2024
Q2
$6.92K Buy
212
+169
+393% +$5.86K ﹤0.01% 2241
2024
Q1
$1.67K Hold
43
– – ﹤0.01% 2560
2023
Q4
$1.32K Sell
43
-57
-57% -$1.43K ﹤0.01% 2615
2023
Q3
$2.23K Hold
100
– – ﹤0.01% 1814
2023
Q2
$2.15K Hold
100
– – ﹤0.01% 1728
2023
Q1
$2.4K Hold
100
– – ﹤0.01% 1573
2022
Q4
$2.32K Buy
+100
New +$2.02K ﹤0.01% 1400

Other funds holding COLL

Farther Finance Advisors's COLL Position: Q3 2026 in Review

Farther Finance Advisors increased its Collegium Pharmaceutical (COLL) stake by 23% in Q3 2026, buying an estimated $90K and bringing the position to 16,406 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

Farther Finance Advisors first reported a position in COLL in Q4 2022 and has held it in 16 quarters since. The position peaked at $482K in Q2 2026. 7 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Farther Finance Advisors held 16,406 shares of Collegium Pharmaceutical worth $358K as of Q3 2026.
  • Farther Finance Advisors bought 3,082 Collegium Pharmaceutical shares in Q3 2026, an estimated $90K.
  • Collegium Pharmaceutical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1852 holding.
  • Farther Finance Advisors first reported a position in Collegium Pharmaceutical in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Collegium Pharmaceutical position peaked at $482K in Q2 2026.
  • 7 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.